Recruiting

Genetic Status

Sponsor:

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Code:

NCT05911932

Conditions

Dementia, Frontotemporal

Alzheimer Dementia (AD)

Lewy Body Dementia (LBD)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biosample collection.

Study Details

Brief summary:

The causes of neurodegenerative dementias such as Frontotemporal Dementia, Lewy Body Disease and Alzheimer's disease are still largely unknown. While the contribution of some genetic mutations and polymorphisms is associated with autosomal dominant patterns of inheritance of these dementias, in many cases, the specific causative mutation in these families is not yet identified. Further, in many patients, polygenic risk is thought to give rise to pathophysiologic changes, but which specific genes affect risk are largely yet unknown. By examining genotypes in patients that present to our Cognitive Neurology and Alzheimer's Research Clinic with suspected or confirmed neurodegenerative dementia, or have a history of a familial dementia, we aim to help identify and characterize genetic mutations or polymorphisms that give rise to neurodegenerative diseases.

Conditions

Dementia, Frontotemporal

Alzheimer Dementia (AD)

Lewy Body Dementia (LBD)

Study ID

NCT05911932

Start date

Oct 20, 2023

Status verified date

Mar, 2025

Completion date

Aug, 2043

Anticipated

Primary completion date

Aug, 2038

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Persons presenting to the cognitive clinic with a neurodegenerative disorder (for example, AD, FTD, LBD, ALSP, and related conditions);
  • Biological family members of someone diagnosed with a neurodegenerative disorder, presenting to clinic;
  • Age 18+ years old;
  • Consenting to a blood draw.

Exclusion Criteria:

• Persons declining / unwilling / not able to have a blood draw.

Study Design

Enrollment

1000 participants

Anticipated

Interventions and Outcome Measures

Interventions

Biosample collection.

Blood draw.

Primary outcome measure

  • Blood draw for genetic status or polymorphism result. [ Time Frame: A one-time visit, taking the participant approximately 20 minutes total for all study procedures. ]

Central Contacts and Locations

Locations

Parkwood Institute

Recruiting

London, Ontario, Canada, N6C 0A7

Contacts

S Jesso, BA

519-646-6000

More Information

Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Last update posted

Mar 4, 2025

Last verified

Mar, 2025

Keywords

  • Neurodegenerative disorders

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's on 2025-03-04.